HomeGlossaryEpigenetic Clock

Epigenetic Clock

Longevity & MortalityUpdated June 2026

Definition

An epigenetic clock is a statistical measure of biological age constructed from patterns of chemical modification at specific sites in the genome, calibrated to predict chronological age in reference populations and then used to estimate how much faster or slower an individual is aging biologically than the chronological-age average.

Why it matters

Epigenetic clocks are the most widely used quantitative measures of biological age currently available, providing a numerical estimate that researchers and clinicians can compare across individuals and populations. The development of these clocks transformed aging research from a primarily descriptive field into one with a tractable measurement, which in turn made it possible to test whether specific interventions actually affect biological aging rates.

How it works

Epigenetic clocks are constructed from measurements of DNA methylation — the addition of methyl groups to specific sites on the DNA strand, which accumulates in characteristic patterns over the life course. The first widely adopted clock was the Horvath clock published in 2013, which used 353 methylation sites across multiple human tissues to predict chronological age with high accuracy in reference populations. The Hannum clock, published the same year, used 71 sites and was calibrated primarily on blood samples. Subsequent generations — GrimAge, PhenoAge, and others — were trained not to predict chronological age but to predict mortality or disease risk more directly, producing measures of biological age that diverge more sharply from chronological age and better predict age-related outcomes. The discrepancy between an individual's clock-estimated age and their chronological age (sometimes called age acceleration) is interpreted as a measure of biological aging rate, with positive values suggesting accelerated biological aging and negative values suggesting slower biological aging. The clocks are correlational instruments, not mechanistic ones — they identify methylation patterns associated with aging but do not by themselves explain why those patterns produce the associated mortality risk.

In practice

For an individual, epigenetic clocks are the form in which biological age is operationally measured in research and increasingly in commercial direct-to-consumer testing. Commercial tests using various clock generations are available, though the validation, standardization, and clinical interpretation of these tests vary considerably across providers and are not at the level required for use in actuarial pricing. A professional advising on longevity or retirement income should be aware that an individual's epigenetic clock result is informative as a personal data point about aging trajectory, but is not currently a basis for revising lifetime income arrangements or expectations. The research literature on epigenetic clocks continues to evolve rapidly — newer clocks calibrated on different outcomes, in different populations, and using different methylation platforms produce different results, and the field has not yet settled on which clock is most appropriate for which application.

In the Longevity Standard Framework

Epigenetic clocks are supporting vocabulary in the Longevity Standard framework. The framework's actuarial model does not currently accept epigenetic clock measurements as inputs — it operates on chronological age, sex, and demographic mortality data with Society of Actuaries credibility scaling. Epigenetic clocks are one of the candidate measurement instruments that could, with further standardization and validation, support a future framework extension in which biological age supplements chronological age as a mortality assumption input for individualized analysis.

  • Biological age versus chronological age
  • Biological aging
  • DNA methylation
  • Horvath clock
  • Hallmarks of aging
  • Mortality rate
  • Longevity heterogeneity
  • Underwriting in longevity context